SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-088054
Filing Date
2022-08-10
Accepted
2022-08-09 17:40:36
Documents
14
Period of Report
2022-08-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2222955d1_8k.htm   iXBRL 8-K 30195
2 EXHIBIT 10.1 tm2222955d1_ex10-1.htm EX-10.1 104418
3 EXHIBIT 99.1 tm2222955d1_ex99-1.htm EX-99.1 8592
  Complete submission text file 0001104659-22-088054.txt   345955

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bstg-20220808.xsd EX-101.SCH 3033
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstg-20220808_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstg-20220808_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2222955d1_8k_htm.xml XML 3278
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 221149639
SIC: 3841 Surgical & Medical Instruments & Apparatus